Trial intelligence / Profile preview

Lung Deposition of BDP/Formoterol NEXT DPI

NCT01176747Phase 2Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Aug 2010
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of beclomethasone dipropionate, formoterol in asthma, chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Aug 2010; status: completed.

02

Drugs

beclomethasone dipropionateformoterol
03

Conditions

asthmachronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01176747.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01176747.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call